Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes and Moderate Renal Impairment (Chronic Kidney Disease Stage 3A): The DERIVE Study

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - June 11, 2018 Category: Endocrinology Authors: Paola Fioretto MD , Stefano Del Prato MD , John B Buse MD, PhD , Ronald Goldenberg MD , Francesco Giorgino MD , Daniel Reyner DrPH , Anna Maria Langkilde MD , C. David Sj ӧstrӧm MD , Peter Sartipy PhD , Source Type: research